rs201141455
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_005271.5(GLUD1):c.646+16_646+17delTA variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0011 in 1,451,450 control chromosomes in the GnomAD database, including 18 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_005271.5 intron
Scores
Clinical Significance
Conservation
Publications
- hyperinsulinism-hyperammonemia syndromeInheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae), Orphanet, PanelApp Australia
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00572 AC: 870AN: 151974Hom.: 8 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00149 AC: 375AN: 250880 AF XY: 0.00113 show subpopulations
GnomAD4 exome AF: 0.000557 AC: 724AN: 1299360Hom.: 10 AF XY: 0.000460 AC XY: 301AN XY: 654814 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00572 AC: 870AN: 152090Hom.: 8 Cov.: 32 AF XY: 0.00574 AC XY: 427AN XY: 74344 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:2
Variant summary: GLUD1 c.646+16_646+17delTA alters non-conserved nucleotides located at a position not widely known to affect splicing. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.0015 in 250880 control chromosomes in the gnomAD database, including 5 homozygotes. The observed variant frequency is approximately 2391.58 fold of the estimated maximal expected allele frequency for a pathogenic variant in GLUD1 causing Congenital Hyperinsulinism phenotype (6.3e-07). To our knowledge, no occurrence of c.646+16_646+17delTA in individuals affected with Congenital Hyperinsulinism and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 418235). Based on the evidence outlined above, the variant was classified as benign. -
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Hyperinsulinism-hyperammonemia syndrome Benign:2
- -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at